Cardiac Pacing, Artificial
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
BiotronikRate-adaptive pacemaker: accelerometer
BiotronikImplantation of the Solia CSP S pacing lead for LBBAP
MedtronicMedtronic Dual-Chamber Pacemaker
Clinical Trials (3)
Total enrollment: 762 patients across 3 trials
Closed Loop Stimulation, Cognitive Performance, and Quality of Life in Pacemaker Patients
Start: May 2006Est. completion: Mar 2011405 patients
Phase 4Completed
BIO|MASTER.CSP Study
Start: Oct 2024Est. completion: Sep 2027152 patients
N/AActive Not Recruiting
Optimize RV Selective Site Pacing Clinical Trial
Start: Jan 2007Est. completion: May 2009205 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.